Cargando…
New-Onset Crohn's Disease following Initiation of Secukinumab: A Case Report and Review of the Role of IL-17 in the Pathogenesis of Crohn's Disease
Patients with autoimmune conditions show a high expression of proinflammatory cytokines including interleukin (IL)-17. While IL-17 inhibitors have demonstrated efficacy in managing autoimmune disorders, rare instances of de novo or exacerbated inflammatory bowel disease (IBD) have been reported. The...
Autores principales: | Khouri, Anas, Moreno, Cesar, Niland, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228216/ https://www.ncbi.nlm.nih.gov/pubmed/37260537 http://dx.doi.org/10.1155/2023/1769290 |
Ejemplares similares
-
Role of the IL23/IL17 Pathway in Crohn’s Disease
por: Schmitt, Heike, et al.
Publicado: (2021) -
Pathogenesis of Crohn's disease
por: Boyapati, Ray, et al.
Publicado: (2015) -
An Unusual Initial Presentation of Elderly-Onset Crohn’s Disease
por: Raddawi, Kenan, et al.
Publicado: (2020) -
Secukinumab-Induced Crohn's Disease in a Patient Treated for Juvenile Idiopathic Arthritis
por: Edupuganti, Srujan, et al.
Publicado: (2023) -
Asymptomatic Crohn’s disease identified in a patient being treated
with secukinumab: A case report
por: Haidari, Wasim, et al.
Publicado: (2019)